Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1H-Pyrazole-1-carboxamidine hydrochloride, a pyrazole derivative, is a heterocyclic compound characterized by its white to light yellow crystalline appearance. It is widely recognized for its stability and versatility in various chemical and pharmaceutical applications, particularly in the synthesis of nonsteroidal anti-inflammatory drugs (NSAIDs) and antihypertensive drugs.

4023-02-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 4023-02-3 Structure
  • Basic information

    1. Product Name: 1H-Pyrazole-1-carboxamidine hydrochloride
    2. Synonyms: AMIDINOPYRAZOLE HCL;1H-PYRAZOLE-1-CARBOXAMIDINE HYDROCHLORIDE;1H-PYRAZOLE-1-CARBOXAMIDINE MONOHYDROCHLORIDE;1H-PYRAZOLE-1-CARBAMIDINE HCL;1-AMIDINOPYRAZOLE HYDROCHLORIDE;1-AMIDINOPYRAZOLE MONOHYDROCHLORIDE;PYRAZOLE CARBOXAMIDINE HCL;PYRAZOLE-1-CARBOXAMIDINE
    3. CAS NO:4023-02-3
    4. Molecular Formula: C4H6N4*ClH
    5. Molecular Weight: 146.58
    6. EINECS: 429-520-1
    7. Product Categories: Pyrazoles & Triazoles;Miscellaneous Reagents;Pyrazoles & Triazoles;Heterocycles;amine
    8. Mol File: 4023-02-3.mol
  • Chemical Properties

    1. Melting Point: 167-170 °C(lit.)
    2. Boiling Point: 891.5oC at 760 mmHg。 产品描述 安全性:
    3. Flash Point: 493oC
    4. Appearance: White to light yellow/Crystals or Crystalline Powder
    5. Density: 2.2 g/cm3
    6. Vapor Pressure: 0.00111mmHg at 25°C
    7. Refractive Index: N/A
    8. Storage Temp.: Inert atmosphere,Room Temperature
    9. Solubility: N/A
    10. Water Solubility: Soluble
    11. BRN: 5448758
    12. CAS DataBase Reference: 1H-Pyrazole-1-carboxamidine hydrochloride(CAS DataBase Reference)
    13. NIST Chemistry Reference: 1H-Pyrazole-1-carboxamidine hydrochloride(4023-02-3)
    14. EPA Substance Registry System: 1H-Pyrazole-1-carboxamidine hydrochloride(4023-02-3)
  • Safety Data

    1. Hazard Codes: Xi,C
    2. Statements: 36/37/38-36/37-34
    3. Safety Statements: 26-37/39-45-36/37/39
    4. WGK Germany: 3
    5. RTECS:
    6. F: 10-21
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 4023-02-3(Hazardous Substances Data)

4023-02-3 Usage

Uses

1. Used in Pharmaceutical Synthesis:
1H-Pyrazole-1-carboxamidine hydrochloride is used as a key intermediate for the development of various pharmaceutical compounds, including NSAIDs and antihypertensive drugs. Its pyrazole ring serves as the main core structure in these medications, contributing to their therapeutic properties.
2. Used in Peptide Synthesis:
As a stable and versatile reagent, 1H-Pyrazole-1-carboxamidine hydrochloride is employed in the efficient and chemically specific guanylation of sterically unhindered primary and secondary aliphatic amines under mild conditions. This makes it a useful reagent in the synthesis of peptides, which are essential components of proteins and have significant biological functions.
3. Used in the Preparation of Guanidylated Hollow Fiber Membranes:
1H-Pyrazole-1-carboxamidine hydrochloride is utilized in the preparation of guanidylated hollow fiber membranes, which are crucial in various biotechnological and medical applications, such as hemodialysis and filtration systems.
4. Used in the Guanylation of Amines and Peptide Synthesis:
1H-Pyrazole-1-carboxamidine hydrochloride is also used for the guanylation of amines, a process that involves the attachment of guanidine groups to a molecule. This modification can enhance the reactivity and biological activity of the target molecule, making it a valuable tool in the synthesis of various peptides and other bioactive compounds.
5. Used in the Synthesis of Bis-guanidinium-Cholesterol Derivatives:
1H-Pyrazole-1-carboxamidine hydrochloride is employed in the synthesis of bis-guanidinium-cholesterol derivatives, which have potential applications in the development of new drugs and therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 4023-02-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,0,2 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 4023-02:
(6*4)+(5*0)+(4*2)+(3*3)+(2*0)+(1*2)=43
43 % 10 = 3
So 4023-02-3 is a valid CAS Registry Number.
InChI:InChI=1/C4H5N3O.ClH/c5-4(8)7-3-1-2-6-7;/h1-3H,(H2,5,8);1H

4023-02-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A2055)  1-Amidinopyrazole Hydrochloride  >98.0%(HPLC)(T)

  • 4023-02-3

  • 5g

  • 320.00CNY

  • Detail
  • TCI America

  • (A2055)  1-Amidinopyrazole Hydrochloride  >98.0%(HPLC)(T)

  • 4023-02-3

  • 25g

  • 980.00CNY

  • Detail
  • Alfa Aesar

  • (H60631)  1H-Pyrazole-1-carboxamidine hydrochloride, 99%   

  • 4023-02-3

  • 10g

  • 431.0CNY

  • Detail
  • Alfa Aesar

  • (H60631)  1H-Pyrazole-1-carboxamidine hydrochloride, 99%   

  • 4023-02-3

  • 50g

  • 1268.0CNY

  • Detail
  • Sigma-Aldrich

  • (Y0001703)  ZanamivirimpurityF  European Pharmacopoeia (EP) Reference Standard

  • 4023-02-3

  • Y0001703

  • 1,880.19CNY

  • Detail
  • Aldrich

  • (402516)  1H-Pyrazole-1-carboxamidinehydrochloride  99%

  • 4023-02-3

  • 402516-10G

  • 726.57CNY

  • Detail
  • Aldrich

  • (402516)  1H-Pyrazole-1-carboxamidinehydrochloride  99%

  • 4023-02-3

  • 402516-50G

  • 2,403.18CNY

  • Detail

4023-02-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 1H-Pyrazole-1-carboxamidine hydrochloride

1.2 Other means of identification

Product number -
Other names N-GUANYLPYRAZOLE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4023-02-3 SDS

4023-02-3Synthetic route

tert-butyl (1H-pyrazol-1-ylcarbonoimidoyl)carbamate
152120-61-1

tert-butyl (1H-pyrazol-1-ylcarbonoimidoyl)carbamate

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

Conditions
ConditionsYield
With sulfuric acid; sodium chloride In neat (no solvent) at 20℃; for 3h; Sealed tube;99%
CYANAMID
420-04-2

CYANAMID

1H-pyrazole hydrochloride
35877-22-6

1H-pyrazole hydrochloride

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

Conditions
ConditionsYield
at 80℃; for 0.1h;98%
NH-pyrazole
288-13-1

NH-pyrazole

CYANAMID
420-04-2

CYANAMID

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane for 2h; Heating;95%
With hydrogenchloride In 1,4-dioxane for 2h; Heating;90%
With hydrogenchloride In 1,4-dioxane for 1h; Reflux;43%
With hydrogenchloride In 1,4-dioxane
With hydrogenchloride In 1,4-dioxane
malonaldehydebis(dimethylacetal)
102-52-3

malonaldehydebis(dimethylacetal)

aminoguanidine bicarbonate
2582-30-1

aminoguanidine bicarbonate

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In water at 20 - 45℃;70.3%
malonaldehydebis(dimethylacetal)
102-52-3

malonaldehydebis(dimethylacetal)

1-aminoguanidine hydrochloride
1937-19-5

1-aminoguanidine hydrochloride

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

Conditions
ConditionsYield
In water at 45℃; for 1h;
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

tert-butyl (1H-pyrazol-1-ylcarbonoimidoyl)carbamate
152120-61-1

tert-butyl (1H-pyrazol-1-ylcarbonoimidoyl)carbamate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h;100%
With triethylamine In dichloromethane; N,N-dimethyl-formamide at 4 - 20℃; for 8h; Inert atmosphere;91%
With potassium carbonate In water; acetone at 20℃;88%
1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

(1S,3R)-3-amino-cyclopentanecarboxylic acid methyl ester hydrochloride

(1S,3R)-3-amino-cyclopentanecarboxylic acid methyl ester hydrochloride

methyl (1S,3R)-3-carbamimidamidocyclopentane-1-carboxylate
959680-24-1

methyl (1S,3R)-3-carbamimidamidocyclopentane-1-carboxylate

Conditions
ConditionsYield
With triethylamine In acetonitrile at 70℃; for 4h;100%
1-[4-[[(2-pyridinylmethyl)amino]methyl]phenyl]methylamine
298681-03-5

1-[4-[[(2-pyridinylmethyl)amino]methyl]phenyl]methylamine

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

C15H19N5

C15H19N5

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 20℃; for 2h;100%
1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

benzyl-methyl-amine
103-67-3

benzyl-methyl-amine

N-benzyl-N-methylguanidine hydrochloride
330-69-8

N-benzyl-N-methylguanidine hydrochloride

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;100%
With N-ethyl-N,N-diisopropylamine In DMF (N,N-dimethyl-formamide) at 20℃;100%
1-(2-aminoethyl)-5,5-dimethyl-imidazolidine-2,4-dione
893433-60-8

1-(2-aminoethyl)-5,5-dimethyl-imidazolidine-2,4-dione

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

N-[2-(5,5-dimethyl-2,4-dioxo-imidazolidin-1-yl)-ethyl]-guanidine hydrochloride
893433-72-2

N-[2-(5,5-dimethyl-2,4-dioxo-imidazolidin-1-yl)-ethyl]-guanidine hydrochloride

Conditions
ConditionsYield
In acetonitrile for 16h; Heating / reflux;100%
N-BOC-1,2-diaminoethane
57260-73-8

N-BOC-1,2-diaminoethane

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

guanidine N-[2-(amidinoamino)ethyl](tert-butoxy)carboxamide, hydrochloride

guanidine N-[2-(amidinoamino)ethyl](tert-butoxy)carboxamide, hydrochloride

Conditions
ConditionsYield
In acetonitrile100%
N1,N1'-(1,10-phenanthroline-4,7-diyl)dibutane-1,4-diamine
1204587-47-2

N1,N1'-(1,10-phenanthroline-4,7-diyl)dibutane-1,4-diamine

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

1,1'-(4,4'-(1,10-phenanthroline-4,7-diyl)bis(azanediyl)bis(butane-4,1-diyl))diguanidine
1204587-52-9

1,1'-(4,4'-(1,10-phenanthroline-4,7-diyl)bis(azanediyl)bis(butane-4,1-diyl))diguanidine

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 60℃;100%
N1,N1'-(1,10-phenanthroline-4,7-diyl)diethane-1,2-diamine
1204587-46-1

N1,N1'-(1,10-phenanthroline-4,7-diyl)diethane-1,2-diamine

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

1,1'-(2,2'-(1,10-phenanthroline-4,7-diyl)bis(azanediyl)bis(ethane-2,1-diyl))diguanidine
1204587-50-7

1,1'-(2,2'-(1,10-phenanthroline-4,7-diyl)bis(azanediyl)bis(ethane-2,1-diyl))diguanidine

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 60℃;100%
1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

N1,N1'-(1,10-phenanthroline-4,7-diyl)dipropane-1,3-diamine
156492-35-2

N1,N1'-(1,10-phenanthroline-4,7-diyl)dipropane-1,3-diamine

1,1'-(3,3'-(1,10-phenanthroline-4,7-diyl)bis(azanediyl)bis(propane-3,1-diyl))diguanidine
1204587-51-8

1,1'-(3,3'-(1,10-phenanthroline-4,7-diyl)bis(azanediyl)bis(propane-3,1-diyl))diguanidine

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 60℃;100%
5-tert-butoxycarbonylamino-1-aminopentane
51644-96-3

5-tert-butoxycarbonylamino-1-aminopentane

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

trifluoroacetic acid
76-05-1

trifluoroacetic acid

tert-butyl N-(5-guanidinopentyl)carbamate trifluoroacetate

tert-butyl N-(5-guanidinopentyl)carbamate trifluoroacetate

Conditions
ConditionsYield
Stage #1: 5-tert-butoxycarbonylamino-1-aminopentane; 1H-pyrazole-1-carboximidamide hydrochloride With triethylamine In dichloromethane at 20℃; Inert atmosphere;
Stage #2: trifluoroacetic acid
100%
1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

4-(2-methoxy-phenyl)-[1,4]diazepane-1-carboxylic acid tret-butyl ester
152943-97-0

4-(2-methoxy-phenyl)-[1,4]diazepane-1-carboxylic acid tret-butyl ester

C13H20N4O

C13H20N4O

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃;100%
4-(3-aminopropoxy)-N-(2-phenoxyphenyl)benzamide

4-(3-aminopropoxy)-N-(2-phenoxyphenyl)benzamide

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

trifluoroacetic acid
76-05-1

trifluoroacetic acid

N-(2-phenoxyphenyl)-4-(3-guanidinopropoxy)benzamide trifluoroacetate

N-(2-phenoxyphenyl)-4-(3-guanidinopropoxy)benzamide trifluoroacetate

Conditions
ConditionsYield
Stage #1: 4-(3-aminopropoxy)-N-(2-phenoxyphenyl)benzamide; 1H-pyrazole-1-carboximidamide hydrochloride With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 44h; Inert atmosphere;
Stage #2: trifluoroacetic acid In water; acetonitrile
100%
(10H-phenoxazin-10-yl)(4-(3-aminopropoxy))phenylmethanone

(10H-phenoxazin-10-yl)(4-(3-aminopropoxy))phenylmethanone

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

trifluoroacetic acid
76-05-1

trifluoroacetic acid

(10H-phenoxazin-10-yl)(4-(3-guanidinopropoxy))phenylmethanone trifluoroacetate

(10H-phenoxazin-10-yl)(4-(3-guanidinopropoxy))phenylmethanone trifluoroacetate

Conditions
ConditionsYield
Stage #1: (10H-phenoxazin-10-yl)(4-(3-aminopropoxy))phenylmethanone; 1H-pyrazole-1-carboximidamide hydrochloride With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 44h; Inert atmosphere;
Stage #2: trifluoroacetic acid In water; acetonitrile
100%
1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

(6S,11Z,13S)-6-amino-8-(1',3'-dioxan-2'-yl)-2-methyl-13-triisopropylsiloxypentadeca-2,11-diene
246266-26-2

(6S,11Z,13S)-6-amino-8-(1',3'-dioxan-2'-yl)-2-methyl-13-triisopropylsiloxypentadeca-2,11-diene

N-{(S)-5-Methyl-1-[2-((Z)-(S)-5-triisopropylsilanyloxy-hept-3-enyl)-[1,3]dioxan-2-ylmethyl]-hex-4-enyl}-guanidine; hydrochloride

N-{(S)-5-Methyl-1-[2-((Z)-(S)-5-triisopropylsilanyloxy-hept-3-enyl)-[1,3]dioxan-2-ylmethyl]-hex-4-enyl}-guanidine; hydrochloride

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide99%
4-aminophenyl-cellulose

4-aminophenyl-cellulose

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

4-[1-(1H-pyrazol-1-yl-iminomethyl)triazen-3-yl]phenyl-cellulose

4-[1-(1H-pyrazol-1-yl-iminomethyl)triazen-3-yl]phenyl-cellulose

Conditions
ConditionsYield
Stage #1: 4-aminophenyl-cellulose With hydrogenchloride; sodium nitrite In water at 0℃; for 3h;
Stage #2: 1H-pyrazole-1-carboximidamide hydrochloride With sodium hydrogencarbonate In water at 0 - 20℃; for 15h;
99%
1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

Allyl chloroformate
2937-50-0

Allyl chloroformate

1H-pyrazole-N-allyloxycarbonyl-1-carboxamidine
277334-62-0

1H-pyrazole-N-allyloxycarbonyl-1-carboxamidine

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 4h;99%
4-(4-chlorophenyl) piperazine
38212-33-8

4-(4-chlorophenyl) piperazine

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

4-(4-chloro-phenyl)-piperazine-1-carboximidic acid amide
17238-60-7

4-(4-chloro-phenyl)-piperazine-1-carboximidic acid amide

Conditions
ConditionsYield
Stage #1: 4-(4-chlorophenyl) piperazine; 1H-pyrazole-1-carboximidamide hydrochloride With N-ethyl-N,N-diisopropylamine In ethanol for 7h; Heating / reflux;
Stage #2: With water In ethanol
99%
n-Octylamine
111-86-4

n-Octylamine

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

octylguanidinium chloride

octylguanidinium chloride

Conditions
ConditionsYield
In neat (no solvent) at 25℃; for 0.17h; Sonication;99%
In acetonitrile for 3h; Reflux;59%
In ethanol at 35℃; for 48h;
4-methoxy-N-methylbenzylamine

4-methoxy-N-methylbenzylamine

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

N-[(4-methoxyphenyl)methyl]-N-methylguanidine hydrochloride
1344719-01-2

N-[(4-methoxyphenyl)methyl]-N-methylguanidine hydrochloride

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 16h;98%
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 16h;45%
4-azatetracyclo[5.4.2.02,6.08.11]tridecane hydrochloride

4-azatetracyclo[5.4.2.02,6.08.11]tridecane hydrochloride

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

4-amidino-4-azatetracyclo[5.4.2.02,6.08.11]tridecane hydrochloride

4-amidino-4-azatetracyclo[5.4.2.02,6.08.11]tridecane hydrochloride

Conditions
ConditionsYield
With triethylamine In acetonitrile for 6h; Reflux;98%
1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

1-(o-fluorophenyl)piperazine
1011-15-0

1-(o-fluorophenyl)piperazine

4-(4-fluorophenyl)piperazine-1-carboximidamide
77723-19-4

4-(4-fluorophenyl)piperazine-1-carboximidamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃;97%
AmBisome
1397-89-3

AmBisome

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

guanidine-AmB
1033521-39-9

guanidine-AmB

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 16h; Inert atmosphere;97%
2,5-dioxopyrrolidin-1-yl methylcarbamate
18342-66-0

2,5-dioxopyrrolidin-1-yl methylcarbamate

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

N'-(N-methylcarbamoyl)-1H-pyrazole-1-carboxamidine

N'-(N-methylcarbamoyl)-1H-pyrazole-1-carboxamidine

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 9h; Inert atmosphere;97%
C106H140N10S

C106H140N10S

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

C114H156N26S

C114H156N26S

Conditions
ConditionsYield
Stage #1: C106H140N10S With N-ethyl-N,N-diisopropylamine In tetrahydrofuran; methanol at 20℃; for 1h;
Stage #2: 1H-pyrazole-1-carboximidamide hydrochloride In tetrahydrofuran; methanol at 20℃; for 24h;
97%
3-[3-(5-chloro-2-methoxyphenylsulfonyloxy)-5-methylphenoxy]propoxyamine
208642-83-5

3-[3-(5-chloro-2-methoxyphenylsulfonyloxy)-5-methylphenoxy]propoxyamine

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

3-[3-(5-chloro-2-methoxyphenylsulfonyloxy)-5-methylphenoxy]propoxyguanidine hydrochloride

3-[3-(5-chloro-2-methoxyphenylsulfonyloxy)-5-methylphenoxy]propoxyguanidine hydrochloride

Conditions
ConditionsYield
In N,N-dimethyl-formamide; acetonitrile96%
5-(4-aminobutoxy)-2-(6-aminohexanamido)-N-(4-phenoxyphenyl)benzamide
1192471-20-7

5-(4-aminobutoxy)-2-(6-aminohexanamido)-N-(4-phenoxyphenyl)benzamide

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

5-(4-guanidinobutoxy)-2-(6-guanidinohexanamido)-N-(4-phenoxyphenyl)benzamide dihydrochloride

5-(4-guanidinobutoxy)-2-(6-guanidinohexanamido)-N-(4-phenoxyphenyl)benzamide dihydrochloride

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide Inert atmosphere;96%
3-azatetracyclo[5.2.1.15,8.01,5]undecane hydrochloride

3-azatetracyclo[5.2.1.15,8.01,5]undecane hydrochloride

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

3-amidino-3-azatetracyclo[5.2.1.15,8.01,5]undecane hydrochloride

3-amidino-3-azatetracyclo[5.2.1.15,8.01,5]undecane hydrochloride

Conditions
ConditionsYield
With triethylamine In acetonitrile at 70℃; for 6h;96%
1-(4-methylphenyl)-3,3,3-trifluoropropan-1-one
121194-34-1

1-(4-methylphenyl)-3,3,3-trifluoropropan-1-one

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

4-fluoro-2-(1H-pyrazol-1-yl)-6-(p-tolyl)pyrimidine

4-fluoro-2-(1H-pyrazol-1-yl)-6-(p-tolyl)pyrimidine

Conditions
ConditionsYield
With potassium hydrogencarbonate In 1,4-dioxane at 60℃;96%

4023-02-3Relevant articles and documents

Design, syntheses, and transfection biology of novel non-cholesterol-based guanidinylated cationic lipids

Sen, Joyeeta,Chaudhuri, Arabinda

, p. 812 - 820 (2005)

The design of efficacious cationic transfection lipids with guanidinium headgroups is an actively pursued area of research in nonviral gene delivery. Herein, we report on the design, syntheses, and gene transfection properties of six novel non-cholesterol-based cationic amphiphiles (1-6) with a single guanidinium headgroup in transfecting CHO, COS-1, MCF-7, A549, and HepG2 cells. The in vitro gene transfer efficiencies of lipids 1-6 were evaluated using both the reporter gene and the whole cell histochemical X-gal staining assays. The efficiencies of lipids 1-3, in particular, were found to be about 2- to 4-fold higher than that of commercially available LipofectAmine in transfecting COS-1, CHO, A-549, and MCF-7 cells. However, the relative transfection efficiencies of lipids 1-3 and LipofectAmine were found to be comparable in HepG2 cells. Cholesterol was found to be a more efficacious co-lipid than dioleoyllphosphatidyl ethanolamine (DOPE). In general, lipids 1-3 containing the additional quaternized centers were observed to be more transfection efficient than lipids 4-6 with less positive headgroups. MTT-assay-based cell viability measurements in representative CHO cells revealed high (>75%) cell viabilities of lipids 1-6 across the lipid/DNA charge ratios 0.1:1 to 3:1. Electrophoretic gel patterns observed in DNase I protection experiments support the notion that enhanced degradation of DNA associated with lipoplexes of lipids 4-6 might play some role in diminishing their in vitro gene transfer efficacies. Size and global surface charge measurement by a dynamic laser light scattering instrument equipped with ζ-sizing capacity revealed the nanosizes and surface potentials of both the transfection efficient and the incompetent lipoplexes to be within the range of 200-600 nm and +3.4 to -34 mV, respectively. To summarize, given the feasibility of a wide range of structural manipulations in the headgroup regions of non-cholesterol-based cationic amphiphiles, our present findings are expected to broaden the potential of cationic amphiphiles with guanidinium headgroups for use in nonviral gene therapy.

Solvent-freeN-Boc deprotection byex situgeneration of hydrogen chloride gas

De Borggraeve, Wim M.,Gilles, Philippe,Van Mileghem, Seger,Verschueren, Rik H.

supporting information, p. 5782 - 5787 (2021/07/12)

An efficient, scalable and sustainable method for the quantitative deprotection of thetert-butyl carbamate (N-Boc) protecting group is described, using down to near-stoichiometric amounts of hydrogen chloride gas in solvent-free conditions. We demonstrate theex situgeneration of hydrogen chloride gas from sodium chloride and sulfuric acid in a two-chamber reactor, introducing a straightforward method for controlled and stoichiometric release of HCl gas. The solvent-free conditions allow deprotection of a wide variety ofN-Boc derivatives to obtain the hydrochloride salts in quantitative yields. The procedure obviates the need for any work-up or purification steps providing an uncomplicated green alternative to standard methods. Due to the solvent-free, anhydrous conditions, this method shows high tolerance towards acid sensitive functional groups and furnishes expanded functional group orthogonality.

Dimethoxyphenyl derivatives, preparation method and composition for anti-inflammatory and skin whitening comprising the same

-

Paragraph 0233-0236, (2018/05/03)

The present invention relates to a dimethoxyphenyl derivatives, to a preparation method thereof, and to an anti-inflammatory and skin whitening composition comprising the same, wherein a compound represented by the chemical formula 1 according to the present invention has excellent solubility, is excellent in an effect of inhibiting the activity of NF-andkappa;B transcription factor, and thus may be useful for prevention, improvement or treatment of inflammatory diseases, and has an excellent inhibitory effect on melanin formation due to alpha-melanocyte stimulating hormone (andalpha;-MSH) inhibitory activity, thereby being useful as a cosmetic composition for preventing, improving or treating melanin pigment over-deposition disease and for whitening the skin.COPYRIGHT KIPO 2018

Conformations, conformational preferences, and conformational exchange of N′-substituted N -acylguanidines: Intermolecular interactions hold the key

Kleinmaier, Roland,Keller, Max,Igel, Patrick,Buschauer, Armin,Gschwind, Ruth M.

experimental part, p. 11223 - 11233 (2010/10/04)

Guanidine and acylguanidine groups are crucial structural features of numerous biologically active compounds. Depending on the biological target, acylguanidines may be considered as considerably less basic bioisosteres of guanidines with improved pharmacokinetics and pharmacodynamics, as recently reported for N′-monoalkylated N-acylguanidines as ligands of G-protein-coupled receptors (GPCRs). The molecular basis for enhanced ligand-receptor interactions of acylguanidines is far from being understood. So far, only a few and contradictory results about their conformational preferences have been reported. In this study, the conformations, conformational preferences, and conformational exchange of four unprotonated and seven protonated monoalkylated acylguanidines with up to six anions and with bisphosphonate tweezers are investigated by NMR. Furthermore, the effects of the acceptor properties in acylguanidine salts, of microsolvation by dimethylsulfoxide, and of varying acyl and alkyl substituents are studied. Throughout the whole study, exclusively two out of eight possible acylguanidine conformations were detected, independent of the compound, the anion, or the solvent used. For the first time, it is shown that the strength and number of intermolecular interactions with anions, solvent molecules, or biomimetic receptors decide the conformational preferences and exchange rates. One recently presented and two new crystal structures resemble the conformational preferences observed in solution. Thus, consistent conformational trends are found throughout the structurally diverse compound pool, including two potent GPCR ligands, different anions, and receptors. The presented results may contribute to a better understanding of the mechanism of action at the molecular level and to the prediction and rational design of these biologically active compounds.

PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS

-

, (2010/03/02)

The invention relates to a process for straightening keratin fibres, comprising: (i) a step in which a straightening composition containing at least two denaturing agents is applied to the keratin fibres, (ii) a step in which the temperature of the keratin fibres is raised, using a heating means, to a temperature of between 110 and 250° C.

Guanidine-acylguanidine bioisosteric approach in the design of radioligands: Synthesis of a tritium-labeled NG-propionylargininamide ([3H]-UR-MK114) as a highly potent and selective neuropeptide Y Y1 receptor antagonist

Keller, Max,Pop, Nathalie,Hutzler, Christoph,Beck-Sickinger, Annette G.,Bernhardt, Günther,Buschauer, Armin

supporting information; experimental part, p. 8168 - 8172 (2009/12/07)

Synthesis and characterization of (R)-Nα-(2,2- diphenylacetyl)-N-(4-hydroxybenzyl)-Nω-([2,3- 3H]-propanoyl)-argininamide ([3H]-UR-MK114), an easily accessible tritium-labeled NPY Y1 receptor (Y1R) antagonist (KB: 0.8 nM, calcium assay, HEL cells) derived from the (R)-argininamide BIBP 3226, is reported. The radioligand binds with high affinity (KD, saturation: 1.2 nM, kinetic experiments: 1.1 nM, SK-N-MC cells) and selectivity for Y1R over Y2, Y 4, and Y5 receptors. The title compound is a useful pharmacological tool for the determination of Y1R ligand affinities, quantification of Y1R binding sites, and autoradiography.

Solvent-free synthesis of azole carboximidamides

Zahariev, Sotir,Guarnaccia, Corrado,Lamba, Doriano,?ema?ar, Ma?a,Pongor, Sándor

, p. 9423 - 9426 (2007/10/03)

A one-pot procedure is described for the preparation of azole carboximidamides 2, 3 and guanidinylation of amines with 3. The X-ray crystal structure of 3b, has been determined. A one-pot procedure is described for the preparation of 1H-pyrazole-carboximidamides 2, 1H-benzotriazole-carboximidamides 3 and guanidinylation of amines with 3. The X-ray crystal structure of N,N-dimethyl-1H-benzotriazole-1-carboximidamide 3b, has been determined.

New cellulose-supported reagent: A sustainable approach to guanidines

Porcheddu, Andrea,Giacomelli, Giampaolo,Chighine, Alessandra,Masala, Simonetta

, p. 4925 - 4927 (2007/10/03)

(Chemical Equation Presented) A new cellulose-supported reagent for the synthesis of guanidine in aqueous medium is reported starting from commercially available functionalized cellulose beads. Primary and secondary amines, anilines, and amino acids were transformed to the corresponding guanidines in high yields and under very mild conditions.

1H-Pyrazole-1-carboxamidines: New inhibitors of nitric oxide synthase

Lee, Younghee,Martasek, Pavel,Roman, Linda J,Silverman, Richard B

, p. 2771 - 2774 (2007/10/03)

1H-Pyrazole-1-carboxamidines were prepared as potential inhibitors of the three isozymes of nitric oxide synthase. All of the compounds were found to be competitive inhibitors of all three isoforms. The most selective compound prepared was 1H-pyrazole-N-(3-aminomethylanilino)-1-carboxamidine (14), which is 100-fold selective for nNOS over eNOS with a K(i) value of 2μM. (C) 2000 Elsevier Science Ltd.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4023-02-3